ANNX
Annexon IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$771.70M
P/E Ratio
—
EPS
$-1.20
Beta
1.18
52W High
$7.18
52W Low
$1.85
50-Day MA
$5.62
200-Day MA
$4.67
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Annexon Inc
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for autoimmune and neurodegenerative diseases. The company is headquartered in South San Francisco, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-202.89M |
| Operating Margin | 0.00% |
| Return on Equity | -87.60% |
| Return on Assets | -45.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.26 |
| Price-to-Book | 3.78 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -2.47 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $163.84M |
| Float | $130.10M |
| % Insiders | 0.47% |
| % Institutions | 102.71% |
Historical Volatility
HV 10-Day
64.11%
HV 20-Day
61.48%
HV 30-Day
53.03%
HV 60-Day
61.96%
HV Rank
7.9%
Volatility is currently expanding
Analyst Ratings
Consensus ($13.12 target)
2
Strong Buy7
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026